Sign in
4

Changes in Ownership

Traws Pharma, Inc. Filed Acc 0001681955-26-000002

Options or other derivatives

  • Chief Executive Officer acquired 274,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Dukes Iain D. · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-07-09 Grant or award : show line 1 in the form Stock Option (right to buy) +274,000 274,000 D
Loading xslF345X06/form4-07152026_120715.xml…